Caribou Biosciences, Inc. (CRBU) Operating cash flow 2019–2025
Caribou Biosciences, Inc. (CRBU) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$111.0MFY2025 · since FY2019: -$32.0M → -$111.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$111.0M | +19.7% |
| FY2024 | -$138.2M | -48.1% |
| FY2023 | -$93.3M | -2.6% |
| FY2022 | -$91.0M | -179.7% |
| FY2021 | -$32.5M | +2.1% |
| FY2020 | -$33.2M | -3.8% |
| FY2019 | -$32.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CRBU financial trends
CRBU RevenueCRBU Net incomeCRBU Net marginCRBU Gross profitCRBU Gross marginCRBU Operating incomeCRBU Operating marginCRBU Free cash flowCRBU Capital expendituresCRBU Return on equityCRBU Stock buybacksCRBU Dividends paidCRBU Total assetsCRBU Total liabilitiesCRBU Shareholders’ equityCRBU overview →